Characterization and Application of Intercalated Montmorillonite with Verapamil and its Polymethyl Methacrylate Nanocomposite in Drug Delivery
This work examined two drug delivery systems: the first system studied the adsorption of Verapamil hydrochloride drug into montmorillonite clay (MMT) by intercalation process to prepare MMT-Verapamil hybrid at different intercalating time, temperatures, pH values and initial drug concentrations. The...
Saved in:
| Published in | Polymer-plastics technology and engineering Vol. 53; no. 14; pp. 1425 - 1433 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Philadelphia, PA
Taylor & Francis Group
08.10.2014
Taylor & Francis Taylor & Francis Ltd |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | This work examined two drug delivery systems: the first system studied the adsorption of Verapamil hydrochloride drug into montmorillonite clay (MMT) by intercalation process to prepare MMT-Verapamil hybrid at different intercalating time, temperatures, pH values and initial drug concentrations. The second system includes the preparation of MMT-Verapamil hybrid combined with polymethyl methacrylate via an emulsion polymerization process to produce a novel nanocomposite material to be used in drug delivery. The polymerization process was carried out using an ultrasonic technique to achieve a biologically safe drug delivery system. Best conditions for the intercalation of verapamil hydrochloride drug into the interlayer of MMT clay were found to be at 50°C and 1 hr using pH ranges of 4-6. The prepared MMT-Verapamil hybrid and the produced MMT-verapamil-MMA nanocomposite material were characterized by X-ray diffraction (XRD), scanning electron microscope (SEM) and thermal gravimetric analysis (TGA). The in-vitro release profile of Verapamil in the case of a drug hybrid is faster than the release in the case of a drug nanocomposite in both gastric and intestinal fluids where, in the case of gastric fluid (pH 1.2), about 40% of the loaded drug was released from the drug hybrid in the first 4 h against only 37% in 5 h in the case of drug nanocomposite. Also in the intestinal fluid (pH 7.4), the verapamil release from drug hybrid reached 68% in 5 h against only 57% was released from drug nanocomposites in 7 h. |
|---|---|
| AbstractList | This work examined two drug delivery systems: the first system studied the adsorption of Verapamil hydrochloride drug into montmorillonite clay (MMT) by intercalation process to prepare MMT-Verapamil hybrid at different intercalating time, temperatures, pH values and initial drug concentrations. The second system includes the preparation of MMT-Verapamil hybrid combined with polymethyl methacrylate via an emulsion polymerization process to produce a novel nanocomposite material to be used in drug delivery. The polymerization process was carried out using an ultrasonic technique to achieve a biologically safe drug delivery system. Best conditions for the intercalation of verapamil hydrochloride drug into the interlayer of MMT clay were found to be at 50°C and 1 hr using pH ranges of 4–6. The prepared MMT-Verapamil hybrid and the produced MMT-verapamil-MMA nanocomposite material were characterized by X-ray diffraction (XRD), scanning electron microscope (SEM) and thermal gravimetric analysis (TGA). The in-vitro release profile of Verapamil in the case of a drug hybrid is faster than the release in the case of a drug nanocomposite in both gastric and intestinal fluids where, in the case of gastric fluid (pH 1.2), about 40% of the loaded drug was released from the drug hybrid in the first 4 h against only 37% in 5 h in the case of drug nanocomposite. Also in the intestinal fluid (pH 7.4), the verapamil release from drug hybrid reached 68% in 5 h against only 57% was released from drug nanocomposites in 7 h. This work examined two drug delivery systems: the first system studied the adsorption of Verapamil hydrochloride drug into montmorillonite clay (MMT) by intercalation process to prepare MMT-Verapamil hybrid at different intercalating time, temperatures, pH values and initial drug concentrations. The second system includes the preparation of MMT-Verapamil hybrid combined with polymethyl methacrylate via an emulsion polymerization process to produce a novel nanocomposite material to be used in drug delivery. The polymerization process was carried out using an ultrasonic technique to achieve a biologically safe drug delivery system. Best conditions for the intercalation of verapamil hydrochloride drug into the interlayer of MMT clay were found to be at 50°C and 1 hr using pH ranges of 4-6. The prepared MMT-Verapamil hybrid and the produced MMT-verapamil-MMA nanocomposite material were characterized by X-ray diffraction (XRD), scanning electron microscope (SEM) and thermal gravimetric analysis (TGA). The in-vitro release profile of Verapamil in the case of a drug hybrid is faster than the release in the case of a drug nanocomposite in both gastric and intestinal fluids where, in the case of gastric fluid (pH 1.2), about 40% of the loaded drug was released from the drug hybrid in the first 4 h against only 37% in 5 h in the case of drug nanocomposite. Also in the intestinal fluid (pH 7.4), the verapamil release from drug hybrid reached 68% in 5 h against only 57% was released from drug nanocomposites in 7 h. [PUBLICATION ABSTRACT] This work examined two drug delivery systems: the first system studied the adsorption of Verapamil hydrochloride drug into montmorillonite clay (MMT) by intercalation process to prepare MMT-Verapamil hybrid at different intercalating time, temperatures, pH values and initial drug concentrations. The second system includes the preparation of MMT-Verapamil hybrid combined with polymethyl methacrylate via an emulsion polymerization process to produce a novel nanocomposite material to be used in drug delivery. The polymerization process was carried out using an ultrasonic technique to achieve a biologically safe drug delivery system. Best conditions for the intercalation of verapamil hydrochloride drug into the interlayer of MMT clay were found to be at 50 degree C and 1 hr using pH ranges of 4-6. The prepared MMT-Verapamil hybrid and the produced MMT-verapamil-MMA nanocomposite material were characterized by X-ray diffraction (XRD), scanning electron microscope (SEM) and thermal gravimetric analysis (TGA). The in-vitro release profile of Verapamil in the case of a drug hybrid is faster than the release in the case of a drug nanocomposite in both gastric and intestinal fluids where, in the case of gastric fluid (pH 1.2), about 40% of the loaded drug was released from the drug hybrid in the first 4 h against only 37% in 5 h in the case of drug nanocomposite. Also in the intestinal fluid (pH 7.4), the verapamil release from drug hybrid reached 68% in 5 h against only 57% was released from drug nanocomposites in 7 h. This work examined two drug delivery systems: the first system studied the adsorption of Verapamil hydrochloride drug into montmorillonite clay (MMT) by intercalation process to prepare MMT-Verapamil hybrid at different intercalating time, temperatures, pH values and initial drug concentrations. The second system includes the preparation of MMT-Verapamil hybrid combined with polymethyl methacrylate via an emulsion polymerization process to produce a novel nanocomposite material to be used in drug delivery. The polymerization process was carried out using an ultrasonic technique to achieve a biologically safe drug delivery system. Best conditions for the intercalation of verapamil hydrochloride drug into the interlayer of MMT clay were found to be at 50°C and 1 hr using pH ranges of 4-6. The prepared MMT-Verapamil hybrid and the produced MMT-verapamil-MMA nanocomposite material were characterized by X-ray diffraction (XRD), scanning electron microscope (SEM) and thermal gravimetric analysis (TGA). The in-vitro release profile of Verapamil in the case of a drug hybrid is faster than the release in the case of a drug nanocomposite in both gastric and intestinal fluids where, in the case of gastric fluid (pH 1.2), about 40% of the loaded drug was released from the drug hybrid in the first 4 h against only 37% in 5 h in the case of drug nanocomposite. Also in the intestinal fluid (pH 7.4), the verapamil release from drug hybrid reached 68% in 5 h against only 57% was released from drug nanocomposites in 7 h. |
| Author | Mohamed, W. S. Nasr, H. E. Mostafa, A. B. |
| Author_xml | – sequence: 1 givenname: W. S. surname: Mohamed fullname: Mohamed, W. S. email: wsabry1976@yahoo.com organization: Department of Polymers and Pigments , National Research Center – sequence: 2 givenname: A. B. surname: Mostafa fullname: Mostafa, A. B. organization: Department of Polymers and Pigments , National Research Center – sequence: 3 givenname: H. E. surname: Nasr fullname: Nasr, H. E. organization: Department of Polymers and Pigments , National Research Center |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28839845$$DView record in Pascal Francis |
| BookMark | eNqNkctu1TAQhiNUJE4Lb8DCEkJik4NvcewVqk65VGqBBbC1po7DceXYwfahCg_BM5M0LQsWFavxyN83I_s_ro5CDLaqnhO8JVji15gJTJtGbSkmfKuw4oI-qjakoU0tCCFH1WZB6oV5Uh3nfI0xbuduU_3e7SGBKTa5X1BcDAhCh07H0Tuz9rFH52G-N-Ch2A5dxlCGmJz3Mbhi0Y0re_TNJhhhcP5WdyWjz9FPgy37yaPLuYBJ0-KjjxCiicMY8yK7gM7S4Ts6s979tGl6Wj3uwWf77K6eVF_fvf2y-1BffHp_vju9qA1XotSG9AyEMoyZVlFGLahWyM52vMXUSKYMvTKc0ZZfgRQSqJ3PAmgjFce27dhJ9WqdO6b442Bz0YPLxnoPwcZD1kS0RBAhJP8PlCrWtEywGX3xD3odDynMD9EMS6VEI-mDFGkExorI21l8pUyKOSfb6zG5AdKkCdZL6vo-db2krtfUZ-3l3XDIc2J9gmBc_utSOX-O5M3MvVk5F_qYBriJyXe6wORjupfYg5v-ABk9wq0 |
| CODEN | PPTEC7 |
| CitedBy_id | crossref_primary_10_2174_0929867325666180831151055 crossref_primary_10_2174_1567201820666230410110206 crossref_primary_10_1007_s40005_018_0390_8 crossref_primary_10_1016_j_clay_2018_03_029 crossref_primary_10_3390_jfb9040058 crossref_primary_10_1080_03602559_2016_1163596 crossref_primary_10_1039_C6RA03942A crossref_primary_10_1007_s12668_024_01402_3 |
| Cites_doi | 10.1080/03602559.2011.639335 10.1021/bm005531u 10.1007/s003960100527 10.1016/j.cis.2004.07.015 10.1016/j.ultsonch.2007.12.003 10.1016/j.clay.2006.09.012 10.1016/j.ejpb.2006.11.002 10.1088/0957-4484/19/6/065707 10.1002/app.30114 10.3390/molecules15042439 10.1016/j.ijpharm.2009.03.004 10.1007/s10450-006-0141-4 10.1002/pi.1711 10.1002/jbm.820170305 10.1080/03602559.2013.814146 10.1016/j.ultsonch.2005.03.006 10.1016/j.ejpb.2006.11.023 10.1016/j.jssc.2006.03.019 10.1002/app.12624 10.1002/jps.2600551110 10.1007/s00396-001-0619-2 10.1097/00005176-200101000-00019 10.1002/polb.1991.090290914 10.1002/app.10975 10.1002/app.13499 10.1002/app.29605 10.1016/j.jcis.2011.12.001 10.1021/nl0055052 10.1080/00914037.2012.706839 10.1016/S0022-2860(03)00109-1 10.1016/S0168-3659(03)00133-0 10.1346/CCMN.1989.0370207 10.1021/ma801391p 10.1016/j.clay.2010.04.011 10.1016/0040-6031(96)02946-2 10.1016/S0142-9612(01)00325-8 10.1016/j.clay.2007.01.012 10.1021/jp002290b |
| ContentType | Journal Article |
| Copyright | Copyright National Research Center, Giza, Egypt 2014 2015 INIST-CNRS Copyright National Research Center, Giza, Egypt Copyright National Research Center, Giza, Egypt. 2014 |
| Copyright_xml | – notice: Copyright National Research Center, Giza, Egypt 2014 – notice: 2015 INIST-CNRS – notice: Copyright National Research Center, Giza, Egypt – notice: Copyright National Research Center, Giza, Egypt. 2014 |
| DBID | IQODW AAYXX CITATION 7SR 8FD JG9 7QO FR3 P64 7U5 L7M |
| DOI | 10.1080/03602559.2014.909462 |
| DatabaseName | Pascal-Francis CrossRef Engineered Materials Abstracts Technology Research Database Materials Research Database Biotechnology Research Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts Solid State and Superconductivity Abstracts Advanced Technologies Database with Aerospace |
| DatabaseTitle | CrossRef Materials Research Database Technology Research Database Engineered Materials Abstracts Engineering Research Database Biotechnology Research Abstracts Biotechnology and BioEngineering Abstracts Solid State and Superconductivity Abstracts Advanced Technologies Database with Aerospace |
| DatabaseTitleList | Materials Research Database Materials Research Database Engineering Research Database Materials Research Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Engineering Chemistry Applied Sciences |
| EISSN | 1525-6111 |
| EndPage | 1433 |
| ExternalDocumentID | 3423214991 10_1080_03602559_2014_909462 28839845 909462 |
| Genre | Original Articles Feature |
| GroupedDBID | .7F .QJ 0BK 0R~ 123 29O 4.4 53G 5VS AAAVI AAENE AALDU AAMIU AAPUL AAQRR ABBKH ABCCY ABFIM ABHAV ABJVF ABLIJ ABPEM ABPTK ABQHQ ABTAI ABXUL ACGEJ ACGFS ACTIO ADCVX ADGTB ADXPE AEGYZ AEISY AENEX AEOZL AFKVX AFOLD AFWLO AGDLA AGMYJ AHDLD AIJEM AIRXU AJWEG AKBVH AKOOK ALMA_UNASSIGNED_HOLDINGS ALQZU AQRUH AVBZW AWYRJ BLEHA CCCUG CE4 CS3 DGEBU DKSSO DU5 EBS EJD E~A E~B F5P FUNRP FVPDL GCUZY GTTXZ H13 HF~ HZ~ H~P IPNFZ J.P KYCEM M4Z NA5 NW0 O9- P2P RIG RNANH ROSJB RTWRZ S-T SNACF TCY TFL TFT TFW TTHFI TWF UT5 UU3 V1K WH7 ZGOLN ~S~ 07J 1TA 8W4 AAAJW ABKVM ABXYU ACMLV ADBHG AFWJF AGGGY AGRBW AOWVY AWFQP BDVFT BKMSO C5E CAG COF COQAR CTOBV CXCUG C~V HJQDS IQODW LZ8 NUSFT OCADI OEUFU TAV TCCYZ TFMCV UA2 UB6 UMP AAYXX ABJNI ABPAQ AHDZW CITATION TBQAZ TDBHL TUROJ 7SR 8FD JG9 7QO FR3 P64 7U5 L7M |
| ID | FETCH-LOGICAL-c496t-c1f3a69c33c79232ea9768ded4702c839c2bc43274ba868a2e3276a258940e7d3 |
| ISSN | 0360-2559 |
| IngestDate | Fri Oct 25 08:58:34 EDT 2024 Thu Oct 24 23:40:27 EDT 2024 Thu Oct 10 22:23:34 EDT 2024 Thu Oct 10 16:54:25 EDT 2024 Fri Aug 23 03:14:56 EDT 2024 Thu Nov 24 18:19:28 EST 2022 Tue Jun 13 19:52:23 EDT 2023 |
| IsPeerReviewed | false |
| IsScholarly | false |
| Issue | 14 |
| Keywords | Organic clay Montmorillonite Control release polymer Calcium antagonist Temperature effect Methyl methacrylate polymer Drug carrier Drug delivery Experimental study Property processing relationship In vitro Composite material Thermal stability Thermal properties Verapamil hydrochloride Emulsion Emulsion polymerization Morphology Preparation Verapamil Nanocomposite Methyl methacrylate Release |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c496t-c1f3a69c33c79232ea9768ded4702c839c2bc43274ba868a2e3276a258940e7d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PQID | 1560091863 |
| PQPubID | 1016350 |
| PageCount | 9 |
| ParticipantIDs | proquest_journals_3089965823 proquest_journals_1560091863 proquest_miscellaneous_1671616684 proquest_miscellaneous_1629357363 crossref_primary_10_1080_03602559_2014_909462 pascalfrancis_primary_28839845 informaworld_taylorfrancis_310_1080_03602559_2014_909462 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-10-08 |
| PublicationDateYYYYMMDD | 2014-10-08 |
| PublicationDate_xml | – month: 10 year: 2014 text: 2014-10-08 day: 08 |
| PublicationDecade | 2010 |
| PublicationPlace | Philadelphia, PA |
| PublicationPlace_xml | – name: Philadelphia, PA – name: New York |
| PublicationTitle | Polymer-plastics technology and engineering |
| PublicationYear | 2014 |
| Publisher | Taylor & Francis Group Taylor & Francis Taylor & Francis Ltd |
| Publisher_xml | – name: Taylor & Francis Group – name: Taylor & Francis – name: Taylor & Francis Ltd |
| References | CIT0030 CIT0010 CIT0032 CIT0031 CIT0034 CIT0011 CIT0033 Shen D. (CIT0028) 2004; 45 CIT0014 CIT0036 Patel H.A. (CIT0043) 2007; 92 CIT0013 CIT0035 CIT0016 CIT0038 CIT0015 CIT0037 CIT0018 CIT0017 CIT0039 CIT0019 CIT0041 CIT0040 CIT0021 CIT0020 CIT0042 CIT0001 CIT0023 CIT0045 CIT0022 CIT0044 Mehrdad M. (CIT0012) 2013; 52 CIT0003 CIT0047 CIT0024 CIT0046 CIT0005 CIT0027 CIT0004 Zabotin K.P. (CIT0025) 1972; 77 CIT0026 CIT0007 CIT0029 CIT0006 CIT0009 CIT0008 |
| References_xml | – ident: CIT0011 doi: 10.1080/03602559.2011.639335 – ident: CIT0027 doi: 10.1021/bm005531u – ident: CIT0009 doi: 10.1007/s003960100527 – ident: CIT0042 doi: 10.1016/j.cis.2004.07.015 – ident: CIT0029 doi: 10.1016/j.ultsonch.2007.12.003 – ident: CIT0044 doi: 10.1016/j.clay.2006.09.012 – ident: CIT0014 doi: 10.1016/j.ejpb.2006.11.002 – ident: CIT0004 doi: 10.1088/0957-4484/19/6/065707 – ident: CIT0045 doi: 10.1002/app.30114 – ident: CIT0001 doi: 10.3390/molecules15042439 – ident: CIT0021 doi: 10.1016/j.ijpharm.2009.03.004 – ident: CIT0022 doi: 10.1007/s10450-006-0141-4 – ident: CIT0003 doi: 10.1002/pi.1711 – ident: CIT0033 doi: 10.1002/jbm.820170305 – ident: CIT0030 doi: 10.1080/03602559.2013.814146 – ident: CIT0031 doi: 10.1016/j.ultsonch.2005.03.006 – ident: CIT0016 doi: 10.1016/j.ejpb.2006.11.023 – ident: CIT0046 doi: 10.1016/j.jssc.2006.03.019 – ident: CIT0007 doi: 10.1002/app.12624 – volume: 77 start-page: 1651412 year: 1972 ident: CIT0025 publication-title: Chem. Abstr. contributor: fullname: Zabotin K.P. – ident: CIT0047 doi: 10.1016/j.ejpb.2006.11.023 – ident: CIT0023 doi: 10.1002/jps.2600551110 – ident: CIT0041 doi: 10.1007/s10450-006-0141-4 – ident: CIT0038 doi: 10.1016/j.ijpharm.2009.03.004 – volume: 52 start-page: 57 year: 2013 ident: CIT0012 publication-title: Int. J. Polym. Mater. contributor: fullname: Mehrdad M. – ident: CIT0015 doi: 10.1007/s003960100527 – ident: CIT0017 doi: 10.1007/s00396-001-0619-2 – ident: CIT0005 doi: 10.1097/00005176-200101000-00019 – ident: CIT0026 doi: 10.1002/polb.1991.090290914 – volume: 92 start-page: 1004 year: 2007 ident: CIT0043 publication-title: Curr. Sci. contributor: fullname: Patel H.A. – ident: CIT0024 doi: 10.1002/app.10975 – ident: CIT0010 doi: 10.1002/app.13499 – ident: CIT0040 doi: 10.1002/app.29605 – ident: CIT0037 doi: 10.1016/j.jcis.2011.12.001 – ident: CIT0036 doi: 10.1021/nl0055052 – volume: 45 start-page: 21 year: 2004 ident: CIT0028 publication-title: Polymer contributor: fullname: Shen D. – ident: CIT0032 doi: 10.1080/00914037.2012.706839 – ident: CIT0018 doi: 10.1016/S0022-2860(03)00109-1 – ident: CIT0006 doi: 10.1016/S0168-3659(03)00133-0 – ident: CIT0020 doi: 10.1346/CCMN.1989.0370207 – ident: CIT0034 doi: 10.1021/ma801391p – ident: CIT0039 doi: 10.1016/j.clay.2010.04.011 – ident: CIT0019 doi: 10.1016/0040-6031(96)02946-2 – ident: CIT0008 doi: 10.1016/S0142-9612(01)00325-8 – ident: CIT0013 doi: 10.1016/j.clay.2007.01.012 – ident: CIT0035 doi: 10.1021/jp002290b |
| SSID | ssj0007255 |
| Score | 1.7216749 |
| Snippet | This work examined two drug delivery systems: the first system studied the adsorption of Verapamil hydrochloride drug into montmorillonite clay (MMT) by... |
| SourceID | proquest crossref pascalfrancis informaworld |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 1425 |
| SubjectTerms | Applied sciences Biological and medical sciences Clay Composites Drug delivery Drug delivery systems Drugs Electron microscopes Emulsion Emulsion polymerization Exact sciences and technology Fluid dynamics Fluid flow Fluids Forms of application and semi-finished materials General pharmacology Hybrid systems Intercalation Interlayers Medical sciences Methyl methacrylate Montmorillonite Nanocomposites Nanostructure Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Polymer industry, paints, wood Polymethyl methacrylate Scanning electron microscopy Technology of polymers Thermal analysis Thermogravimetric analysis Ultrasonic methods Verapamil hydrochloride |
| Title | Characterization and Application of Intercalated Montmorillonite with Verapamil and its Polymethyl Methacrylate Nanocomposite in Drug Delivery |
| URI | https://www.tandfonline.com/doi/abs/10.1080/03602559.2014.909462 https://www.proquest.com/docview/1560091863 https://www.proquest.com/docview/3089965823 https://search.proquest.com/docview/1629357363 https://search.proquest.com/docview/1671616684 |
| Volume | 53 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9MwGLZKdwAOCAZohTEZiWum1HYc51h1myq0DQ4tq7hErpuySVszpemh_Aj-DH-Q942dr62qgEsUJY2t9Hny-rHfDxPyiauEGQkI-CEznuijf1fh2cxP5jJgoSrKF19cytFEfJ4G007ndyNqaZ3Pjs3PrXkl_4MqXANcMUv2H5CtGoULcA74whEQhuNfYTysqi3bZMrCEzCoXdJlnkgGQGiUlvAF53dpdoPOdtCadhX2G2Zg4TpH5Uj4mt5ucGvpDUa95tfaZBt8Hk1xijHoGOhVFBs5ydY_wGTdYnBHyz9sW8i8exDnRSHovFrCL3pJ6jKIFeTptb6zS69X9YLsRQrydWEXf-sdoi_1qmDayCVSuGWLvrBxcxXRxo92EGmEMdlsLt_D6Y4dp5xxZgFMdZ1xdtbblhouWSoatrgvbEq1G9eBhnzrmOGCLKFD7A-j_cRxBLNeN0q0SnRffonPJufn8fh0On5C9hhYN9Ule4PRyferSgCErNhst3qFMmMTS7pv6aWliFr1cjFQV6-AIgv7Fz3SC4UIGr8kL9zshQ4sFV-RTrLcJ0-H5aaB--R5o77la_LrIUEpYE8bBKXpgjYJSh8QlCJBaUXQ4nEgKK0JSpsEpS2C0pslRYLSkqBvyOTsdDwceW4DEM-ISOae6S-4lpHh3GCZS5ZoEM9qnsxF6DMD0t6wmRGchWKmlVSaJXAuNQtUJPwknPO3pLtMl8kBoWIO4tRoUMMwBZdcaAAi1AzaVjzxI9MjXglCfG_rvMT9snyuAy1G0GILWo-oJlJxXvDZ4RTz3Y8etVCt-sONvyMlgh45LGGOnbVZxVjxALS9knzrbY7ue5hNMLj9sboN4KP_Ty-TdA1NSND2Qcjlzt-EMAeUUol3u7t5T57Vn_Uh6ebZOvkA-jyfHbnv4Q83QeaO |
| link.rule.ids | 315,783,787,27938,27939 |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+and+Application+of+Intercalated+Montmorillonite+with+Verapamil+and+its+Polymethyl+Methacrylate+Nanocomposite+in+Drug+Delivery&rft.jtitle=Polymer-plastics+technology+and+engineering&rft.au=Mohamed%2C+W+S&rft.au=Mostafa%2C+A+B&rft.au=Nasr%2C+H+E&rft.date=2014-10-08&rft.pub=Taylor+%26+Francis+Ltd&rft.issn=0360-2559&rft.eissn=1525-6111&rft.volume=53&rft.issue=14&rft.spage=1425&rft.epage=1433&rft_id=info:doi/10.1080%2F03602559.2014.909462&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0360-2559&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0360-2559&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0360-2559&client=summon |